EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Thyroid-Stimulating Hormone/Growth Hormone Cosecreting Pituitary Adenoma With Normal Thyroid-Stimulating Hormone Level

Feyza Erenler iD, Benjamin Katcher, Van Phan, Knarik Arkun, Mina G Safain iD

JCEM Case Reports · 27.03.2025 · 3 (5)

DOI: 10.1210/jcemcr/luaf063 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 11.04.2025. Verfasst von Feyza Erenler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid-stimulating hormone (TSH; thyrotropin) adenoma is a rare pituitary tumor that can be missed due to its subtle symptoms. We are reporting a 67-year-old man with history of ventricular fibrillation on amiodarone who presented with acute headache and right third cranial nerve palsy. His computed tomography (CT) scan revealed a 2.2-cm suprasellar mass, consistent with pituitary apoplexy, and he underwent pituitary tumor resection. Preoperational hormonal workup revealed TSH 0.25 mIU/mL (0.25 IU/L) (normal reference range: 0.35-4.94 mIU/mL; 0.35-4.94 IU/L), free thyroxine (T4) 3.17 ng/dL (40.80 pmol/L) (normal reference range: 0.7-1.48 ng/dL; 9.78-19.05 pmol/L), and total triiodothyronine (T3) 91 ng/dL (140 nmol/L) (normal reference range: 58-159 ng/dL; 89-244 nmol/L). Initial differential diagnoses included TSH-producing pituitary adenoma (TSH-oma) and amiodarone-induced thyrotoxicosis. His free T4 declined significantly postoperatively, favoring a TSH-oma diagnosis. The pathology report showed a TSH and growth hormone (GH) cosecreting adenoma. Furthermore, he had a normal thyroid uptake scan, as well as negative thyroid antibodies, making primary thyroid diseases less likely. A high free T4 with normal TSH 3 years ago, prior to the start of amiodarone, suggested a long disease duration. This case demonstrates challenges in diagnosing TSH-oma, especially in patients with normal TSH and concurrent amiodarone use.

Schlagwörter

Stichwörter der Autor:innen

acromegalyamiodarone-induced thyrotoxicosisarrhythmiacosecretionpituitary macroadenomathyroid-stimulating hormone (TSH) secreting pituitary adenoma (TSH-oma)

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, USA.
  • Tufts University School of Medicine, Boston, MA 02111, USA.
  • Department of Pathology, Tufts Medical Center, Boston, MA 02111, USA.
  • Department of Neurosurgery, Tufts Medical Center, Boston, MA 02111, USA.

ORCID-Profile: Feyza Erenler, Mina G Safain

Zitieren

APA

Erenler, F., Katcher, B., Phan, V., Arkun, K., & Safain, M. G. (2025). Thyroid-Stimulating Hormone/Growth Hormone Cosecreting Pituitary Adenoma With Normal Thyroid-Stimulating Hormone Level. JCEM Case Reports, 3(5). https://doi.org/10.1210/jcemcr/luaf063

Vancouver

Erenler F, Katcher B, Phan V, Arkun K, Safain MG. Thyroid-Stimulating Hormone/Growth Hormone Cosecreting Pituitary Adenoma With Normal Thyroid-Stimulating Hormone Level. JCEM Case Reports. 2025;3(5). doi:10.1210/jcemcr/luaf063

BibTeX
@article{Erenler2025,
  author = {Erenler, Feyza and Katcher, Benjamin and Phan, Van and Arkun, Knarik and Safain, Mina G},
  title = {Thyroid-Stimulating Hormone/Growth Hormone Cosecreting Pituitary Adenoma With Normal Thyroid-Stimulating Hormone Level},
  journal = {JCEM Case Reports},
  year = {2025},
  volume = {3},
  number = {5},
  doi = {10.1210/jcemcr/luaf063}
}
Kostenlos starten →